VG Life Sciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
5.70
-
2.70
-
-
Cost of Goods Sold (COGS) incl. D&A
286.80
628.50
-
-
-
Gross Income
281.10
628.50
-
-
-
SG&A Expense
2,356.90
1,078.50
2,577.00
3,757.60
4,143.60
EBIT
2,638.00
3,944.80
2,633.40
3,757.60
4,143.60
Unusual Expense
1,669.00
-
-
2,495.70
679.70
Interest Expense
2,933.50
1,547.20
2,834.50
1,075.90
2,760.00
Pretax Income
7,240.40
5,492.00
5,467.90
7,329.20
6,223.90
Consolidated Net Income
7,240.40
5,492.00
5,467.90
7,329.20
6,223.90
Net Income
7,240.40
5,418.40
5,395.10
7,269.70
6,189.50
Net Income After Extraordinaries
7,240.40
5,418.40
5,395.10
7,269.70
6,189.50
Net Income Available to Common
7,240.40
5,418.40
5,395.10
7,269.70
6,189.50
EPS (Basic)
6.00
6.00
2.53
0.89
0.22
Basic Shares Outstanding
926.50
1,229.60
2,135.10
8,189.50
27,631.90
EPS (Diluted)
7.81
4.41
2.53
0.89
0.22
Diluted Shares Outstanding
926.50
1,229.60
2,135.10
8,189.50
27,631.90
EBITDA
2,570.20
3,944.80
2,574.30
3,757.60
4,143.60
Other Operating Expense
-
2,237.80
-
-
-
Minority Interest Expense
-
73.60
72.80
59.50
34.40
About VG Life Sciences
View Profile
